Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension

Abstract

Objectives Pulmonary hypertension (PH) is a life-threatening progressive disease with high mortality in the elderly. However, the pathogenesis of PH has not been fully understood and there is no effective therapy to reverse the disease process. This study aims to determine whether cellular senescence is involved in the development of PH. Methods The rat PH model was established by intraperitoneal injection of monocrotaline and evaluated by pulmonary arteriole wall thickness and right ventricular hypertrophy index. Human lung fibroblasts (HLFs) were treated with CoCl2 or hypoxia to induce cellular senescence in vitro. SA-β-gal staining and the changes of senescent markers were used to examine cellular senescence. The molecular mechanism of cellular senescence was further explored by detecting reactive oxygen species (ROS) levels and culturing cells with a conditioned medium. Results We revealed the cellular senescence of pulmonary adventitial fibroblasts in vivo in the rat PH model. The expression of Bmi-1, an important regulator of senescence, was decreased in the lungs of PH rats and localized in adventitial fibroblasts. The in vitro experiments showed that p16 expression was increased while Bmi-1 expression was decreased after CoCl2 treatment in HLFs. Mechanistically, Bmi-1 could alleviate CoCl2-induced HLFs senescence by eliminating ROS which further promoted the proliferation of pulmonary artery smooth muscle cells by paracrine mode of action of HLFs. Conclusion Bmi-1 alleviates the cellular senescence of pulmonary fibroblasts in PH, which expands the pathogenesis of PH and provides a theoretical basis for targeting senescent cells in the treatment of PH.

ARID1A knockdown enhances carcinogenesis features and aggressiveness of Caco-2 colon cancer cells: An in vitro cellular mechanism study

“…Normally, the somatic cells has a limited lifespan - they can be replicated (but limitedly) and finally undergo cellular senescence, which is the process of permanent cell cycle arrest. Cellular senescence is a cell protective mechanism that can be detected by measuring the SA-β-gal activity 52 , 53 . Several lines of evidence have reported that suppression of cellular senescence is associated with the enhanced carcinogenesis 54 , 55 .…”

EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II-Induced Vascular Smooth Muscle Cell Senescence

“…Cellular senescence is characterized by loss of proliferation ability, stagnant cell cycle, apoptosis opposition, and anomalous level of secretory phenotype (SASP) factors (IL-6, IL-8, IFN-γ, etc.) of senescence-associated [23][24][25][26]. Senescent cells have now been detected in a group of age-related diseases [24].…”

Identification of differentially expressed genes and signaling pathways in gestational diabetes mellitus by integrated bioinformatics analysis

“…Wang et al [334] found that the altered expression of hsa-mir-657 in GDM. Improta Caria et al [335], Li et al [336], Park et al [337], Cheng et al [338] and Davis, [339] demonstrated that hsa-mir-657, BMI1, GATA4, STAT3 and ATF3 played a pivotal role in the hypertension, but these miRNAs might be novel targets for GDM. Improta Caria et al [335], Patankar et al [340], Bochkis et al [341], Nishimura et al [342], Su et al [343] and Kim et al [344] suggested that hsa-mir-657, GATA4, FOXA2, EP300, STAT3 and ATF3 could induce obesity, but these genes might be novel targets for GDM.…”